Search Results

Evaluation and management of osteoporosis and fragility fractures in the elderly

Authors: Rosenzweig, Andrew; Mishra, Richa

Source: Aging Health, Volume 5, Number 6, December 2009 , pp. 833-850(18)

Publisher: Future Medicine

Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis

Authors: Gennari, Luigi; Merlotti, Daniela; Nuti, Ranuccio

Source: Expert Review of Obstretrics and Gynecology, Volume 4, Number 6, November 2009 , pp. 607-617(11)

Publisher: Expert Reviews

Bazedoxifene: Bazedoxifene Acetate, TSE 424, TSE-424, WAY 140424

Author: Adis International Limited,

Source: Drugs in R&D, Volume 9, Number 3, 2008 , pp. 191-196(6)

Publisher: Adis International

Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: Current State of Development

Authors: Gennari, Luigi; Merlotti, Daniela; Valleggi, Fabrizio; Martini, Giuseppe; Nuti, Ranuccio

Source: Drugs & Aging, Volume 24, Number 5, 2007 , pp. 361-379(19)

Publisher: Adis International

Not all selective estrogen response modulators are created equal: update on lasofoxifene

Author: Goldstein

Source: International Journal of Gynecological Cancer, Volume 16, Supplement 2, September 2006 , pp. 504-504(1)

Publisher: Blackwell Publishing

Developments in the pharmacotherapeutic management of osteoporosis

Authors: Close, Pierre; Neuprez, Audrey; Reginster, Jean-Yves

Source: Expert Opinion on Pharmacotherapy, Volume 7, Number 12, August 2006 , pp. 1603-1615(13)

Publisher: Informa Healthcare

Effects of lasofoxifene on the pharmacokinetics and pharmacodynamics of single-dose warfarin

Authors: Ouellet, Daniele; Bramson, Candace; Carvajal-Gonzalez, Santos; Roman, Doina; Randinitis, Edward; Remmers, Ann; Gardner, Mark J.

Source: British Journal of Clinical Pharmacology, Volume 61, Number 6, June 2006 , pp. 741-745(5)

Publisher: Blackwell Publishing

Estrogen Receptors as Therapeutic Targets in Breast Cancer

Authors: Ariazi, Eric A.; Ariazi, Jennifer L.; Cordera, Fernando; Jordan, V. C.

Source: Current Topics in Medicinal Chemistry, Volume 6, Number 3, February 2006 , pp. 181-202(22)

Publisher: Bentham Science Publishers

Emerging Selective Estrogen Receptor Modulators: Special Focus on Effects on Coronary Heart Disease in Postmenopausal Women

Authors: Vogelvang, Tatjana Elène; Marius Jan van der Mooren,; Mijatovic, Velja; Kenemans, Peter

Source: Drugs, Volume 66, Number 2, 2006 , pp. 191-221(31)

Publisher: Adis International

Urogenital effects of selective estrogen receptor modulators: a systematic review

Authors: Albertazzi, P.; Sharma, S.

Source: Climacteric, Volume 8, Number 3, September 2005 , pp. 214-220(7)

Publisher: Informa Healthcare

Other US regulatory news

Source: Inpharma, Volume 1, Number 1506, 2005-09-24 , pp. 22-22(1)

Publisher: Adis International

Lasofoxifene: CP 336156, CP-336156

Author: Adis International Limited

Source: Drugs in R&D, Volume 6, Number 1, 2005 , pp. 56-60(5)

Publisher: Adis International

Battling Bone Disease: New Drugs Strengthen the Osteoporosis Market

Author: Adis International Limited

Source: Pharmaceutical & Diagnostic Innovation, Volume 2, Number 6, November 2004 , pp. 3-8(6)

Publisher: Adis International

Novel therapies for osteoporosis

Author: Biskobing D.M.

Source: Expert Opinion on Investigational Drugs, Volume 12, Number 4, 1 April 2003 , pp. 611-621(11)

Publisher: Informa Healthcare

Target specificity of selective estrogen receptor modulators within human endometrial cancer cells

Authors: Bramlett K.S.; Burris T.P.

Source: The Journal of Steroid Biochemistry and Molecular Biology, Volume 86, Number 1, July 2003 , pp. 27-34(8)

Publisher: Elsevier